“Phase II Trial of Romidepsin (FK228 or Depsipeptide) in Peripheral T-Cell Lymphoma: Clinical Activity and Molecular Markers”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 2 (13). https://doi.org/10.4081/hmr.v2i13.482.